Tag: IP

Addressing Excipient Grade Variability During Supplier Qualification: A Comprehensive Investigation Approach Variability in excipient grade during supplier qualification can severely impact formulation performance and stability, potentially leading to significant deviations,…

Investigation into Supplier Grade Substitution During Scale-Up: Addressing Formulation Failures During the scale-up process within pharmaceutical manufacturing, the substitution of raw materials, particularly excipients, can lead to unexpected formulation failures.…

Examining Excipient Incompatibility with API During Scale-Up: Navigating Regulatory Scrutiny The challenge of excipient incompatibility with active pharmaceutical ingredients (API) during scale-up is a growing concern in the pharmaceutical industry.…

Implications of Unjustified Excipient Selection in Stability Assessments The selection of excipients for pharmaceutical formulations is critical to ensuring drug quality and efficacy. However, unjustified choices in excipient selection during…

Addressing Unjustified Excipient Selection During Stability Assessment In the pharmaceutical industry, the selection of excipients during formulation development is critical, particularly during stability assessments. Choosing an inappropriate excipient can adversely…

Understanding Excipient Incompatibility with APIs During Stability Assessments: An Investigation Approach Excipient incompatibility with active pharmaceutical ingredients (APIs) during stability assessments is a critical issue that can jeopardize product quality…

Managing Supplier Grade Substitutions During Regulatory Reviews to Avoid Late-Stage Reformation In an evolving regulatory landscape, the risk of supplier grade substitution during the review process can significantly impact pharmaceutical…

Understanding Excipient Incompatibility with API: Preventing Late-Stage Reformulation As pharmaceutical companies continually strive for innovation and efficiency in formulation development, the challenges associated with excipient incompatibility with active pharmaceutical ingredients…

Addressing Functional Performance Failures During Stability Assessments Functional performance failures during stability assessments can lead to significant challenges in pharmaceutical manufacturing and quality assurance. These failures often signal potential issues…

Assessing Variability in Excipient Grade Through a Robust Supplier Qualification Process Variability in excipient grade during supplier qualification presents significant risks to pharmaceutical manufacturing quality, particularly concerning API compatibility and…

Understanding the Implications of Supplier Grade Substitution During Qualification: An Investigation In the dynamic environment of pharmaceutical manufacturing, supplier grade substitution poses significant challenges, especially during the qualification process. This…

Addressing Functional Performance Failures During Stability Assessments in Pharmaceutical Manufacturing Functional performance failures during stability assessments can significantly impact the integrity and compliance of pharmaceutical products. These failures often draw…